Understanding how a specific immune receptor protects the brain in autoimmune diseases.
Protective role of Clec7a/dectin-1 in CNS autoimmunity
This study is looking at how a special protein called dectin-1 helps protect the brain and nervous system from damage caused by autoimmune diseases like multiple sclerosis, with the hope of finding new ways to treat these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10989963 on NIH RePORTER |
What this research studies
This research investigates the role of dectin-1, a receptor involved in the immune response, in protecting the central nervous system (CNS) from damage caused by autoimmune diseases like multiple sclerosis (MS). The study focuses on how dectin-1 interacts with immune cells and brain cells to promote neuroprotection during conditions such as experimental autoimmune encephalomyelitis (EAE). By using animal models, the researchers aim to uncover the mechanisms through which dectin-1 exerts its protective effects, potentially leading to new therapeutic strategies for MS and similar conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis or related autoimmune conditions affecting the central nervous system.
Not a fit: Patients with non-autoimmune neurological disorders or those not diagnosed with multiple sclerosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the brain's defense against autoimmune damage, improving outcomes for patients with multiple sclerosis.
How similar studies have performed: Previous research has shown promising results regarding the role of immune receptors in neuroprotection, suggesting that this approach may yield significant insights.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Shinohara, Mari L. — Duke University
- Study coordinator: Shinohara, Mari L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.